Striatal β-amyloid in dementia with Lewy bodies but not Parkinson’s disease
- 9 April 2011
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 118 (5) , 713-719
Abstract
Professor Jellinger first identified that striatal Aβ deposition at postmortem seemed to differentiate cases of dementia with Lewy bodies (DLB) from those with Parkinson’s disease dementia (PDD), a finding subsequently questioned. Our replication study in 34 prospectively studied cases assessed the ability of striatal Aβ deposition to differentiate DLB from PDD, and also assessed the relationship between striatal and cortical Aβ deposition and α-synuclein-immunoreactive pathologies, using previously published protocols. Cases with DLB had significantly shorter durations and greater dementia severities compared with cases with PDD. Striatal Aβ-immunoreactive plaques were only consistently found in cases with DLB and correlated with both the severity (positive correlation) and duration (negative correlation) of dementia. Striatal Aβ-immunoreactive plaques also positively correlated with the severity of α-synuclein-immunoreactive pathologies as well as cortical Aβ-positive plaques. Striatal Aβ deposition positively predicted dementia in Lewy body cases with high specificity and had the greatest sensitivity to differentiate DLB from PDD with 100% negative predictive value. These data suggest that striatal Aβ deposition in Lewy body diseases contributes to early dementia and in these cases may impact on the efficacy of treatments targeting the striatum.Keywords
This publication has 18 references indexed in Scilit:
- Imaging amyloid deposition in Lewy body diseasesNeurology, 2008
- Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson’s disease patientsActa Neuropathologica, 2008
- Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodiesInternational Journal of Geriatric Psychiatry, 2005
- Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross‐sectional comparative studyMovement Disorders, 2003
- Prevalence of amyloid‐β deposition in the cerebral cortex in Parkinson's diseaseMovement Disorders, 2002
- Cortical Lewy body pathology in the diagnosis of dementiaActa Neuropathologica, 2001
- Diagnostic Criteria for Parkinson DiseaseArchives of Neurology, 1999
- Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.1997
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- ParkinsonismNeurology, 1967